This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report. Business Insider Intelligence offers even more healthcare coverage with Digital Health Pro. Subscribe today to receive industry-changing digital health news and analysis to your inbox. 
A new class of medicine — digital therapeutics (DTx) — has emerged, offering a novel means of treating the swelling number of patients with chronic diseases and keeping associated costs down.
Digital therapeutics deliver evidence-based therapies via software — often in the form of consumer-facing mobile health apps — that replace or complement the existing treatment of a disease. They diverge from the broader digital health market in that they must be approved by regulatory bodies — and displaying proof-of-concept is at the core of their model.
See the rest of the story at Business Insider
See Also:
- Change Healthcare bought pharmacy IT company PDX for $200 million
- Verizon launches 5G network to enhance virtual health
- LabCorp teamed up with Medable to enable clinical trial participants to engage remotely
from Feedburner https://ift.tt/2MSEFH5
No comments:
Post a Comment